Company news

IDT Australia Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Continuous Growth in Quarterly Sales and Positive Outlook

April 26, 2023

IDT Achieves Key Milestone with TGA License Upgrade

March 27, 2023

Appointment of Permanent CEO

March 2, 2023

Appendix 4D and Half Year Report - 31 December 2022

February 22, 2023

IDT Australia Limited - CEO Change

September 14, 2022

IDT Australia Investor Highlights 2022

August 30, 2022

IDT Australia Appendix 4E 30 June 2022

August 30, 2022

IDT Australia Limited - MMI T2 Stream Grant Outcome

August 25, 2022

Application for quotation of securities - IDT

April 3, 2022

MMI (Collaboration Stream) Grant Outcome

March 17, 2022

Pause in Trading

March 17, 2022

Appendix 2A

March 2, 2022

IDT Australia Half Year Report 31 December 2021

February 22, 2022

IDT Australia FY22 Interim Results and Investor Update

February 22, 2022

Half Yearly Report

February 22, 2022

IDT Onshore mRNA Manufacturing ATM Outcome & StrategyUpdate

December 15, 2021

IDT Executes Manufacturing Agreement With Monash

October 12, 2021

IDT Receives Sterile Licence From The TGA

September 28, 2021

Supplementary Disclosure - Sterile Readiness Agreement

September 15, 2021

Response to ASX Query

September 7, 2021

IDT Australia Investor Highlights 2021

August 25, 2021

IDT Australia Appendix 4E 30 June 2021

August 24, 2021

Media Interest, MIPS COVID-19 Vaccine & Sterile Readiness

August 23, 2021

Response to ASX Price Query

August 19, 2021

COVID-19 Vaccine Manufacture discussions with VicGov & MIPS

June 22, 2021

COVID19 Vaccine Feasibility Assessment

March 19, 2021

IDT Australia FY21 Interim Results and Investor Update

February 23, 2021

Half Yearly Report and Accounts

February 23, 2021

IDT Australia Investor Highlights 2020

August 25, 2020

Appendix 4E

August 25, 2020

Cann Group Executes New Export Supply Agreements

May 25, 2020

Business Update - COVID-19

April 8, 2020

Medicinal Cannabis GMP manufacturing update

April 2, 2020

Half Year Results Presentation

February 20, 2020

Appendix 4D

February 20, 2020

Commercial-Scale GMP Medicinal Cannabis Resin Extraction

January 6, 2020

Termination of Distribution Agreement

December 23, 2019

Australian produced medicinal cannabis product

December 18, 2019

Investor and Medicinal Cannabis Update

October 20, 2019

FDA lifts Warning Letter

September 3, 2019

STRATEGIC UPDATE - Medicinal Cannabis Manufacturing

August 29, 2019

FDA revises IDTs Facility Inspection Classification

August 27, 2019

ODC medicinal cannabis manufacturing permit secured

August 27, 2019

IDT secures Medicinal Cannabis manufacturing license

May 19, 2019

Appendix 4D - Half Year Report

February 19, 2019

Investor Presentation to AGM

October 22, 2018

On-Market Share Buy-back and Small Parcel Buy-back

September 25, 2018

Preliminary Final Report

August 21, 2018

and Cann Group Medicinal Cannabis Partnership

August 6, 2018

Appointment of Chief Executive Officer

July 1, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 33 decks. Every deck is listed under its year.